Max Healthcare Institute Ltd Share Price
As on 05 June 2026 at 00:27 IST
Max Healthcare Institute Q1 FY26 Results:
Profit for the period increased 30.3% to ₹308 crores in Q1 FY26, from ₹236.3 crores in Q1 FY25. Total income for the quarter increased 30.8% year-on-year to ₹2,064.1 crores from ₹1,577.6 crores.
About Max Healthcare Institute Ltd
Max Healthcare Institute Ltd. is one of the largest healthcare organizations in India. It provides a wide range of medical services and facilities. The company was founded in 2001. Max Healthcare Institute has grown to become a significant player in the Indian healthcare industry. The headquarters of the company is located in New Delhi. Its main products and services include hospital services, homecare services (Max@Home), and pathology services (Max Labs). The company falls under the healthcare sector. The company is known for its comprehensive range of medical services and strong market presence. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-4.55%
Over 6 Months
-11.09%
Over 1 Year
-15.22%
Over 3 Years
86.02%
Max Healthcare Institute Ltd Summary
Close ₹965.55
Open ₹941.20
High ₹967.75
Low ₹935.85
Volume 26,09,191
Net Turnover (in Cr) ₹249.9
52Wk High ₹1,314.30
52Wk Low ₹903
52Wk High / Low
903
1,314.30
Max Healthcare Institute Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹93,971.55
EPS (TTM) 7.49
Book Value (BV) 91.86
Div. Yield 0.21 %
P/E (TTM) 131.18
Price/Book Value 10.51
Delivery % 56.33 %
Face Value 10
Key Ratios
PE Ratio 152.11
PB Ratio 12.86
EV to Sales 40.10
PEG Ratio 76.82
ROA 7.85
ROE 8.78
Debt-Equity 0.07
Net Profit Margin 26.32
Operating Profit Margin 42.28
Max Healthcare Institute Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 7,184.10 | 5,582.96 | 4,701.84 | 4,058.82 | 2,619.41 |
| Total Expenses | 5,704.10 | 4,217.64 | 3,638.12 | 3,310.89 | 2,454.36 |
| Profit Before Tax | 1,406.37 | 1,365.32 | 1,063.72 | 738.90 | -68.65 |
| Profit After Tax | 1,075.88 | 1,057.64 | 1,103.51 | 605.05 | -114.50 |
| Operating Profit After Depreciation | 1,645.02 | 1,425.21 | 1,147.58 | 848.80 | 344.51 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 11,497.20 | 8,828.45 | 7,084.58 | 7,063.97 | 6,536.59 |
| Total Non Current Assets | 13,621.91 | 10,293.76 | 8,158.78 | 8,188.84 | 7,419.97 |
| Total Current Assets | 1,592.57 | 1,706.18 | 1,943.07 | 1,000.29 | 1,124.47 |
| Total Assets | 15,214.48 | 11,999.94 | 10,101.85 | 9,189.13 | 8,544.44 |
| Total Shareholder's Fund | 9,380.87 | 8,408.14 | 7,409.59 | 6,282.47 | 5,638.68 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 1,459.31 | 1,121.67 | 1,284.13 | 740.52 | 117.86 |
| Net Cash Used In Investing Activities | -1,614.11 | -1,252.55 | -102.21 | -763.80 | 206.39 |
| Net Cash Used In Financing Activities | -163.80 | -263.74 | -288.56 | -294.17 | 191.33 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 3,030.14 | 2,612.58 | 2,048.83 | 1,903.48 | 1,137.29 |
| Total Expenses | 2,009.79 | 1,747.62 | 1,485.69 | 1,502.99 | 1,073.08 |
| Profit Before Tax | 946.72 | 864.96 | 563.14 | 400.49 | -146.46 |
| Profit After Tax | 701.07 | 687.26 | 694.31 | 331.52 | -164.45 |
| Operating Profit After Depreciation | 1,068.74 | 916.62 | 615.05 | 459.42 | 176.66 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 4,902.79 | 4,823.40 | 4,530.46 | 4,539.21 | 2,989.15 |
| Total Non Current Assets | 9,139.13 | 8,042.11 | 6,984.28 | 7,099.32 | 6,181.10 |
| Total Current Assets | 828.09 | 1,026.76 | 1,436.05 | 712.44 | 961.85 |
| Total Assets | 9,967.22 | 9,068.87 | 8,420.33 | 7,811.76 | 7,142.95 |
| Total Shareholder's Fund | 8,289.36 | 7,680.76 | 7,042.11 | 6,311.38 | 5,939.43 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 598.01 | 613.09 | 696.47 | 447.36 | 219.24 |
| Net Cash Used In Investing Activities | -873.26 | -805.64 | -842.85 | -669.65 | -83.91 |
| Net Cash Used In Financing Activities | -28.81 | -245.91 | -54.47 | -161.48 | 396.68 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 2,142.89 | 2,067.52 | 2,135.47 | 2,027.57 | 1,909.74 |
| Total Expenses | 1,536.46 | 1,529.18 | 1,560.32 | 1,504.66 | 1,398.12 |
| Profit Before Tax | 464.58 | 364.54 | 446.03 | 400.43 | 402.50 |
| Profit After Tax | 342.22 | 300.92 | 491.30 | 307.97 | 319 |
| Operating Profit after Depreciation | 654.26 | 583.72 | 608.05 | 559.42 | 558.54 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 732.90 | 710.91 | 736.62 | 694.02 | 658.70 |
| Total Expenses | 518.03 | 506.58 | 522.95 | 506.31 | 484.09 |
| Profit Before Tax | 260.38 | 225.20 | 215.66 | 222.88 | 227.23 |
| Profit After Tax | 203.21 | 186.95 | 160.42 | 166.03 | 177.39 |
| Operating Profit after Depreciation | 306.21 | 287.66 | 261.10 | 267.56 | 272.76 |
Max Healthcare Institute Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 945.02
S2 924.48
S3 913.12
Pivot 956.38
R1 976.92
R2 988.28
R3 1,008.82
Moving Average
20 SMA 1,017.42
50 SMA 994.48
100 SMA 1,012.92
200 SMA 1,078.51
Max Healthcare Institute Ltd Corporate Actions
Max Healthcare Institute Ltd
₹1.5/Share
Announcement Date 04 Jul 2025
Record Date 04 Jul 2025
Div Yield 15%
Max Healthcare Institute Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,283.55 | ₹1,19,104.74 |
| Fortis Healthcare Ltd | ₹930.10 | ₹70,218.66 |
| Narayana Hrudayalaya Ltd | ₹1,981.35 | ₹40,491.03 |
| Aster DM Healthcare Ltd | ₹729.50 | ₹37,796.93 |
| Global Health Ltd | ₹1,199.65 | ₹32,254.72 |
Max Healthcare Institute Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Invesco India Large & Mid Cap Fund | 7.07% |
| Invesco India Midcap Fund | 4.42% |
| ICICI Pru Focused Equity Fund | 3.10% |
| Motilal Oswal Midcap Fund | 2.23% |
| HDFC Large Cap Fund | 1.72% |
Max Healthcare Institute Ltd News
Board of Max Healthcare Institute recommends final dividend
Of Rs 2 per share
22 May 2026, 10:22 am
Max Healthcare Institute reports 7% YoY rise in Q4 PAT
Max Healthcare Institute reported a 7.27% increase in net profit to Rs 342.22 crore for the fourth quarter ended March 2026, compared with Rs 319 crore posted in the corresponding quarter last year.
21 May 2026, 07:10 pm
Max Healthcare Institute to table results
On 21 May 2026
15 May 2026, 06:25 pm
Max Healthcare Institute allots 51,287 equity shares under ESOS
02 May 2026, 12:05 pm
Max Healthcare gains after deal to acquire over 58% stake in Bhubaneswar-based Kalinga Hospital
Max Healthcare (MHIL) added 1.40% to Rs 945.40 after the company announced that it has entered into a share purchase agreement for acquiring a controlling stake in Kalinga Hospital (KHL) from Hospital Corporation of Orissa Inc.
08 Apr 2026, 01:39 pm
Max Healthcare Institute Ltd Stock Analysis
- Annual revenue for Max Healthcare Institute Ltd increased by 15.98% to ₹3,030.14 crore in FY 2025 from ₹2,612.58 crore in FY 2024.
- Annual Net Profit for Max Healthcare Institute Ltd increased by 2.01% to ₹701.07 crore in FY 2025 from ₹687.26 crore in FY 2024.
- Promoter Shareholding in Max Healthcare Institute Ltd decreased by 0.04% in the most recent quarter, from 23.72% in December 2025 to 23.71% in March 2026.
- Max Healthcare Institute Ltd delivered a 1-year return of -15.22% compared to the Nifty 50, which provided a return of -4.63% as of the last trading session.
- Max Healthcare Institute Ltd share price moved down by 0.85% from its previous close of INR ₹965.55. The latest Max Healthcare Institute Ltd share price is INR ₹957.35.
- Max Healthcare Institute Ltd share price today has been at a low of 956.50 and a high of 967.40. Over the past 52 weeks, the Max Healthcare Institute Ltd share price has seen a low of 903 and a high of 1,314.30.
About Max Healthcare Institute Ltd
Max Healthcare Institute Ltd. is one of the largest healthcare organizations in India. The company provides a wide range of medical services and facilities. It operates hospitals, home care services, and pathology services under the brand names Max@Home and Max Labs, respectively. Max Healthcare is dedicated to delivering high standards of clinical excellence and patient care. These things are supported by the latest technology and cutting-edge research.
Max Healthcare falls under the healthcare sector. The company was founded in 2001, making it over many years old. Since its inception, Max Healthcare has grown to become a significant player in the Indian healthcare industry. The company is known for its comprehensive medical services and patient-centric approach.
The headquarters of Max Healthcare Institute Ltd. is located in New Delhi, India. The company is promoted and led by Abhay Soi, who serves as the Chairman and Managing Director. His leadership has been instrumental in driving the company's growth and success.
Max Healthcare's main products and services include homecare services, hospital services, and pathology services. The company operates 23 healthcare facilities with more than 5,150 beds. It offers a wide range of specialties and medical services. Max@Home provides health and wellness services at home. In comparison, Max Labs offers pathology services outside the hospital network.
Max Healthcare is one of the largest healthcare providers in India, with a strong market presence and a reputation for excellence. The company has an extensive network of hospitals and a comprehensive range of medical services. This has positioned it as a trusted and reliable healthcare provider.
The promoter shareholding of the company stands at 23.74%. This shareholding in Max Healthcare Institute Ltd. is held by Abhay Soi and his associates. Abhay Soi owns 23.73% of the stake from total shareholding. Also, he serves as the chairman and managing director of the company. This demonstrates strong promoter commitment to the business. The crucial managerial promoters of the company include:
Economic Impact Max Healthcare has had a substantial economic impact on the Indian healthcare sector. The company provides a wide range of medical services. Thus, it has facilitated access to quality healthcare for millions of individuals and families. The availability of hospital services, homecare services, and pathology services has enabled individuals to receive timely and effective medical care. This contributes to improved health outcomes and overall well-being. Additionally, this has contributed to economic stability and growth in the regions where Max Healthcare operates.
Patient-Centric Approach One of the significant influences of Max Healthcare is its patient-centric approach. The company focuses on understanding and meeting the specific needs of its patients. This ensures that they receive personalized and comprehensive medical care. Max Healthcare's commitment to patient satisfaction has resulted in high patient retention rates and long-term relationships with patients. The company's emphasis on patient-centricity has set new standards in the healthcare industry. Also, this encourages other players to adopt similar practices.
Innovation and Technological Advancements Max Healthcare is at the forefront of innovation and technological advancements in the healthcare sector. The company leverages advanced technologies such as digital health platforms, telemedicine, and artificial intelligence to enhance its operations and improve patient experience. Max Healthcare embraces these technologies. Thus, the company has improved its operational efficiency, reduced treatment times, and provided innovative medical solutions to its patients. These technological advancements have positioned Max Healthcare as a leader in the healthcare industry.
Corporate Social Responsibility Max Healthcare is committed to corporate social responsibility (CSR). Also, it undertakes various initiatives to support community development. The company's CSR activities focus on healthcare, education, and environmental sustainability. By investing in these areas, Max Healthcare has made a positive impact on the lives of many individuals and communities, fostering social and economic development. The company's CSR initiatives have also enhanced its reputation as a socially responsible and ethical organization.
Max Healthcare Institute Ltd. has made a significant impact on the Indian healthcare sector and the economy. The company has contributed to improved health outcomes and economic growth. This is achieved through its comprehensive range of medical services, patient-centric approach, innovation, and technological advancements. Max Healthcare's focus on corporate social responsibility has further enhanced its influence and reputation. As the company continues to evolve and expand its operations, it remains dedicated to driving healthcare excellence and improving the quality of life for its patients and communities.
Max Healthcare falls under the healthcare sector. The company was founded in 2001, making it over many years old. Since its inception, Max Healthcare has grown to become a significant player in the Indian healthcare industry. The company is known for its comprehensive medical services and patient-centric approach.
The headquarters of Max Healthcare Institute Ltd. is located in New Delhi, India. The company is promoted and led by Abhay Soi, who serves as the Chairman and Managing Director. His leadership has been instrumental in driving the company's growth and success.
Max Healthcare's main products and services include homecare services, hospital services, and pathology services. The company operates 23 healthcare facilities with more than 5,150 beds. It offers a wide range of specialties and medical services. Max@Home provides health and wellness services at home. In comparison, Max Labs offers pathology services outside the hospital network.
Max Healthcare is one of the largest healthcare providers in India, with a strong market presence and a reputation for excellence. The company has an extensive network of hospitals and a comprehensive range of medical services. This has positioned it as a trusted and reliable healthcare provider.
The promoter shareholding of the company stands at 23.74%. This shareholding in Max Healthcare Institute Ltd. is held by Abhay Soi and his associates. Abhay Soi owns 23.73% of the stake from total shareholding. Also, he serves as the chairman and managing director of the company. This demonstrates strong promoter commitment to the business. The crucial managerial promoters of the company include:
- Pranav Amin
- Michael Thomas Neeb
- K Narasimha Murthy
- Anil Kumar Bhatnagar
Influence of the Company
Max Healthcare Institute Ltd. is one of the largest healthcare organizations in India, providing a wide range of medical services and facilities. The company operates hospitals, home care services, and pathology services. Max Healthcare has grown to become a significant player in the Indian healthcare industry. The company is committed to its clinical excellence, patient care, and innovation. This has solidified its position as a trusted name in the healthcare industry.Economic Impact Max Healthcare has had a substantial economic impact on the Indian healthcare sector. The company provides a wide range of medical services. Thus, it has facilitated access to quality healthcare for millions of individuals and families. The availability of hospital services, homecare services, and pathology services has enabled individuals to receive timely and effective medical care. This contributes to improved health outcomes and overall well-being. Additionally, this has contributed to economic stability and growth in the regions where Max Healthcare operates.
Patient-Centric Approach One of the significant influences of Max Healthcare is its patient-centric approach. The company focuses on understanding and meeting the specific needs of its patients. This ensures that they receive personalized and comprehensive medical care. Max Healthcare's commitment to patient satisfaction has resulted in high patient retention rates and long-term relationships with patients. The company's emphasis on patient-centricity has set new standards in the healthcare industry. Also, this encourages other players to adopt similar practices.
Innovation and Technological Advancements Max Healthcare is at the forefront of innovation and technological advancements in the healthcare sector. The company leverages advanced technologies such as digital health platforms, telemedicine, and artificial intelligence to enhance its operations and improve patient experience. Max Healthcare embraces these technologies. Thus, the company has improved its operational efficiency, reduced treatment times, and provided innovative medical solutions to its patients. These technological advancements have positioned Max Healthcare as a leader in the healthcare industry.
Corporate Social Responsibility Max Healthcare is committed to corporate social responsibility (CSR). Also, it undertakes various initiatives to support community development. The company's CSR activities focus on healthcare, education, and environmental sustainability. By investing in these areas, Max Healthcare has made a positive impact on the lives of many individuals and communities, fostering social and economic development. The company's CSR initiatives have also enhanced its reputation as a socially responsible and ethical organization.
Max Healthcare Institute Ltd. has made a significant impact on the Indian healthcare sector and the economy. The company has contributed to improved health outcomes and economic growth. This is achieved through its comprehensive range of medical services, patient-centric approach, innovation, and technological advancements. Max Healthcare's focus on corporate social responsibility has further enhanced its influence and reputation. As the company continues to evolve and expand its operations, it remains dedicated to driving healthcare excellence and improving the quality of life for its patients and communities.
FAQ’s
What is the share price of Max Healthcare Institute Ltd today?
Max Healthcare Institute Ltd share price as on 4 Jun 2026 is ₹ 957.35
What is the Market Cap of Max Healthcare Institute Ltd?
The market cap of Max Healthcare Institute Ltd stock is ₹93,971.55 Cr.
What is the PE Ratio of Max Healthcare Institute Ltd?
The Price to Earnings (P/E) Ratio of Max Healthcare Institute Ltd is 152.11
What is the PB Ratio of Max Healthcare Institute Ltd?
The Price to Book (P/B) Ratio of Max Healthcare Institute Ltd is 12.86
What is the 52 week high of Max Healthcare Institute Ltd Share Price?
The 52 week high of Max Healthcare Institute Ltd share price stands at ₹1,314.30
What is the 52 week low of Max Healthcare Institute Ltd Share Price?
The 52 week low of Max Healthcare Institute Ltd share price stands at ₹903
How can I buy shares of Max Healthcare Institute Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Max Healthcare Institute Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
